As of 2026-05-26, the Fair Value of Solasia Pharma KK (4597.T) is -48.07 JPY. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 25.00 JPY, the upside of Solasia Pharma KK is -292.29%.
With the market price of 25.00 JPY and our fair value calculation, Solasia Pharma KK (4597.T) is not a good investment. Investing in 4597.T stocks now will result in a potential loss of 292.29%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -2,477.00 | -2,548.00 | -1,113.00 | -1,942.00 | -876.00 | -1,791.20 |
| YoY growth | 39.98% | -2.87% | 56.32% | -74.48% | 54.89% | 14.77% |
| Market Cap (mil) | 6,835.25 |
| P/E | |
| Forward P/E |
| EPS | -3.26 |
| Avg earnings growth rate | 14.77% |
| TTM earnings | -890.00 |